PET-imaging of Two Vartumabs in Patients With Solid Tumors

Clinical trial NCT06645808 · RECRUITING

Trial details

NCT number: NCT06645808
Sponsor: Var2 Pharmaceuticals
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Tumor Colon Carcinoma Rectal Carcinoma Osteosarcoma Chondrosarcoma Lung Carcinoma Head and Neck Squamous Cell Carcinoma Esophageal Carcinoma Gastric Carcinoma Pancreas Carcinoma Bladder Carcinoma Glioblastoma

Start date: 2024-12-10
Primary completion: 2026-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.